Involvement of nuclear factor-kappaB in the inhibition of pro-inflammatory mediators by pinosylvin

Planta Med. 2006 Jul;72(9):801-6. doi: 10.1055/s-2006-941545. Epub 2006 Jun 19.

Abstract

Nuclear factor-kappaB (NF-kappaB) is a critical transcription factor for maximal expression of many of the cytokines that are involved in the pathogenesis of inflammatory diseases. In this study, we found that pinosylvin, a natural stilbenoid that is a component of the pine leaf (Pinus densiflora), significantly inhibited LPS-induced NF-kappaB activation in a concentration-dependent manner. Additionally, pinosylvin was found to inhibit the LPS-induced phosphorylation and degradation of IkappaB alpha in THP-1 cells. Therefore, we have attempted to determine whether pinosylvin can inhibit the expression of cytokines possessing NF-kappaB binding sites in their promoter regions. In a consistent result, pinosylvin inhibited LPS-induced production of TNF alpha and interleukin-8 (IL-8). Taken together, these results show that pinosylvin suppresses the production of pro-inflammatory mediators through the inhibition of the NF-kappaB signaling pathway.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Inflammatory Agents / pharmacology*
  • Binding Sites
  • Cell Line
  • Cyclooxygenase 2 / genetics
  • Cyclooxygenase 2 Inhibitors / pharmacology
  • Cytokines / metabolism*
  • Gene Expression Regulation / drug effects
  • Genes, Reporter
  • Humans
  • I-kappa B Proteins / metabolism
  • Interleukin-8 / antagonists & inhibitors
  • Interleukin-8 / genetics
  • Lipopolysaccharides / antagonists & inhibitors
  • Luciferases / analysis
  • NF-kappa B / antagonists & inhibitors
  • NF-kappa B / metabolism
  • NF-kappa B / physiology*
  • Phosphorylation
  • Pinus / chemistry
  • Promoter Regions, Genetic
  • Signal Transduction / drug effects
  • Stilbenes / chemistry
  • Stilbenes / pharmacology*
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors
  • Tumor Necrosis Factor-alpha / genetics

Substances

  • Anti-Inflammatory Agents
  • Cyclooxygenase 2 Inhibitors
  • Cytokines
  • I-kappa B Proteins
  • Interleukin-8
  • Lipopolysaccharides
  • NF-kappa B
  • Stilbenes
  • Tumor Necrosis Factor-alpha
  • pinosylvin
  • Luciferases
  • Cyclooxygenase 2